My watch list
my.chemeurope.com  
Login  

2,Alpha-DMT



2,Alpha-DMT
Systematic (IUPAC) name
 ?
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Chemical data
Formula C12H16N2 
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

2,alpha-DMT, or 2,a-dimethyltryptamine, is a lesser-known psychedelic drug. It is the 2,a-dimethyl analog of DMT. 2,a-DMT was first synthesized by Alexander Shulgin. In his book TiHKAL (Tryptamines I Have Known and Loved), Shulgin lists the dosage as 300-500 mg, and the duration as 7-10 hours.[1] 2,a-DMT causes mydriasis and tingling. It also produces a calm, drunk-like feeling. Very little data exists about the pharmacological properties, metabolism, and toxicity of 2,a-DMT.

Additional recommended knowledge

References

  1. ^ Shulgin, Alexander; Ann Shulgin (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press, 422. ISBN 0-9630096-9-9. OCLC 38503252. 


 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "2,Alpha-DMT". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE